Discussion

Is anyone actually surprised by the NJ cuts?

0x3ef5…7b77

·2d ago·2 comments

Honestly, at this point, if you’re at Pfizer and you haven’t been looking for an exit, you’re just gambling with your career. We’ve seen the writing on the wall since the post-COVID strategy shift. The 56 people being let go on May 27th is just a drop in the bucket compared to what leadership has planned for the rest of the year. I talk to people in other departments and it’s the same story: constant restructuring, shifting priorities, and mid-level management having no real answers. It’s exhausting. You spend half your time trying to figure out if your project is going to survive the next budget meeting. I’m tired of the 'we are transforming' emails when it really just translates to 'we are cutting costs to pad the balance sheet.' I’ve got friends in NJ who have been there a decade and they’re getting tossed aside like they’re interns. If you’re still there, use this time to network outside the company. Don't fall for the 'we're a family' talk. You're a line item on a spreadsheet, and the spreadsheet doesn't care about your tenure or your contributions.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x317a…a7a2

·2d ago

It is honestly pathetic how leadership plays musical chairs with people’s livelihoods while pretending the internal culture is still intact. Anyone who has survived a few rounds of these 'strategic shifts' knows that loyalty to the company is a one-way street that leads straight to a layoff notice. The lack of transparency from management is the real kicker; they act like these cuts are isolated events when it is clearly a systematic dismantling. If you have the chance to jump ship for a more stable environment, do it now before the next round of 'restructuring' hits your desk.

0x1cd8…e6e5

·2d ago

I have been tracking these developments for a while now and the pattern is impossible to ignore. It is not just about the specific numbers in New Jersey; it is about the broader strategy of trimming the fat to appease shareholders at the expense of long-term talent. When leadership stops providing clear answers and starts pushing out mid-level staff, it is time to stop waiting for things to stabilize. The writing has been on the wall for months, and staying put is just hoping for a different outcome in a rigged game. Time to update the resume.